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‘If at first you don’t succeed, try again’. Looking beyond  
the initial results of a failed tuberculosis diagnosis
A. von Braun,1 C. Sekaggya,1 L. Henning,2 R Nakijoba,1 A. Kambugu,1 J. Fehr,2 B. Castelnuovo1
Uganda is among the world’s 22 high tuberculosis (TB) burden countries, with the World Health Or-
ganization (WHO) reporting 47 650 new cases in 2013, 
of which 48% were human immunodeficiency virus 
(HIV) co-infected.1 The primary prevention measure is 
timely TB diagnosis, which remains challenging.2 In 
immunosuppressed patients with TB, atypical clinical 
or radiological features, false-negative sputum micros-
copy findings are common,3 resulting in missed or de-
layed diagnosis. This is associated with increased mor-
tality, and may contribute to ongoing TB transmission. 
The WHO therefore recommends intensive case find-
ing (ICF), particularly in HIV-infected individuals.4 
ICF consists of screening for symptoms of active TB at 
every encounter with a health care facility. A patient is 
considered a presumptive TB patient if he/she reports 
any of the following symptoms: current cough, fever, 
weight loss or night sweats. Presumed TB patients 
need to undergo further investigations in accordance 
with national guidelines and depending on the avail-
ability of diagnostic procedures.
METHODS
Uganda’s Infectious Diseases Institute (IDI) cares for 
approximately 8000 HIV-infected individuals in Kam-
pala. Since 2008, patients have been investigated for 
TB by trained staff supervised by a senior medical offi-
cer in an integrated TB-HIV clinic.5 Approximately 
450 presumed TB patients are seen annually, of which 
300 are diagnosed with TB.
We assessed clinical outcomes among HIV-infected 
presumed pulmonary TB (PTB) patients identified us-
ing ICF and screened for a clinical trial, who were clas-
sified as having ‘no PTB’ after initial investigations 
performed between 29 April and 9 July 2013.
In accordance with the trial’s inclusion criteria, pa-
tients aged 18 years presumed to have a first episode 
of PTB were selected. As recommended by the WHO, 
investigations included chest X-ray, two sputum smear 
tests and an Xpert® MTB/RIF (Cepheid, Sunnyvale, 
CA, USA) result if the sputum smear results were nega-
tive or unavailable.6 Mycobacterium tuberculosis culture 
(Löwenstein-Jensen incubated at 37°C for 8 weeks and 
MGIT™ [Mycobacteria Growth Indicator Tube; BD, 
Sparks, MD, USA] incubated at 37°C for 6 weeks) was 
ordered for every patient. Data were retrospectively 
collected from patient files and electronic medical re-
cords from initial presentation up to October 2014. 
Patients lost to follow-up, defined as failure to return 
to the clinic for 3 consecutive months, were also con-
tacted by telephone.
The study was reviewed and approved by the Mak-
erere University Faculty of Medicine Research and Eth-
ics Committee, Kampala (approval number: 120-
2009), and the Uganda National Council for Science 
and Technology, Kampala, Uganda (HS 683).
RESULTS
During the study period, 73 HIV-infected adults were 
investigated for PTB. Outcomes of investigations are 
shown in the Figure. Following initial investigations, 
32/73 (43.8%) were diagnosed with PTB based on 
positive sputum smear, culture or Xpert results. The 
remaining 41 patients were classified as having ‘no 
PTB’ on the basis of clinical, radiological and myco-
bacterial findings. Of the 41 patients, 36 (87.8%) 
were smear- and culture-negative; 5 (12.2%) were 
unable to produce enough sputum, and therefore 
only had negative results on Xpert. As shown in the 
Table, the demographic characteristics of patients di-
agnosed with PTB and patients classified as having 
‘no PTB’ were similar, apart from a lower median 
CD4 cell count among patients diagnosed with PTB. 
Patients classified as having no PTB were treated 
with antibiotics for presumed lower respiratory tract 
infection. The majority of these patients (29/41, 
70.1%) experienced complete resolution of 
symptoms.
Due to lack of clinical improvement after antibi-
otic treatment, 6/41 (14.6%) patients were re-as-
sessed and underwent further investigations. All 6 
patients were diagnosed with TB within 3 months 
(mean duration 6 weeks), accounting for a total of 
38 TB diagnoses, 15.8% (6/38) of which were de-
layed. For one patient, the delay was due to delayed 
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agnosed with PTB. Of the remaining 41 patients initially 
classified as ‘non-PTB’, six had a delayed PTB diagnosis 
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tion results may reduce morbidity and mortality among 
this vulnerable patient group.
AVB and CS contributed equally 
to this work; JF and BC 
contributed equally to this 
work. 
Public Health Action HIV-infected patients investigated for PTB  171
sputum culture, as his time to positivity was 28 days but the 
laboratory returned the final result only after more than 8 
weeks. One patient was diagnosed using repeat Xpert, and four 
patients were diagnosed with disseminated TB using repeat 
chest X-ray, abdominal ultrasound and lymph node biopsy. By 
the time they were diagnosed with TB, three (50%) had been 
started on antiretroviral treatment (ART) based on immunologi-
cal criteria.
The remaining 6 patients (6/41, 14.6%) were lost to fol-
low-up: 2/6 (33%) were not reachable by phone, while the re-
maining 4/6 (66%) were reported by their relatives to have died.
DISCUSSION AND CONCLUSIONS
Delayed TB diagnosis is a commonly encountered problem 
globally.7 Delayed diagnosis attributed to heath care factors in-
cludes mistaking an atypical clinical presentation for a bacte-
rial, fungal or parasitic infection in patients with smear-nega-
tive TB.8 A cross-sectional study conducted in two districts 
outside of Kampala in 2014 found that 88% of patients treated 
for PTB experienced a health care-related treatment delay.9
Although additional diagnostic procedures were available in 
this clinical trial setting, TB diagnoses were delayed in 6/38 
(15.8%) TB cases. Continued clinical monitoring and enhanced 
diagnostics led to an accurate diagnosis. As symptoms were per-
sistent and not newly occurring, new TB was not suspected af-
ter the initial investigation. Immune reconstitution inflamma-
tory syndrome following initiation of ART in 3/6 patients with 
delayed TB diagnosis most likely contributed to case finding, a 
phenomenon known as ‘unmasking TB’.
The majority (4/6, 66%) of the patients lost to follow-up 
were reported to have died, while the remaining two were not 
traceable. This finding emphasises the importance of active 
tracing and close follow-up of patients investigated for TB. This 
observation has led the integrated TB-HIV clinic at the IDI to 
adopt new internal standard operating procedures: all presumed 
TB cases classified as ‘no TB’ after investigations will be fol-
lowed up at least every 2 weeks and actively traced through 
phone calls and home visits if they do not return for their ap-
pointments. We believe these measures will contribute to reduc-
ing morbidity and mortality among our patients, and increase 
the number of TB diagnoses.
Our study findings are limited by the small sample size. Nev-
ertheless, these data reflect our day-to-day clinical experience 
and sparked a review of standard operating procedures. Our 
findings suggest that ‘excluding TB’ is not a one point in time 
decision but rather a complex diagnostic process. Future studies 
should address whether the additional costs of further investi-
gations warrant diagnostic gains.
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PTB*
(n = 32)
n (%)
‘No PTB’*
(n = 41)
n (%) P value†
Age, years, median [IQR] 34.5 [26–43] 36 [32–41.5] 0.301
Male sex 17 (53.1) 13 (31.7) 0.065
CD4 cell count, cells/µl, median [IQR] 69 [9–385] 312 [224–435] 0.02
BMI, kg/m2, median [IQR] 19.0 [16.5–22.4] 20.9 [17.8–22.9] 0.18
On antiretroviral treatment 12 (37.5) 20 (48.8) 0.335
Symptoms 
 Cough 32 (100) 41 (100) —
 Fever 26 (81.2) 26 (63.4) 0.095
 Night sweats 25 (78.1) 23 (56.1) 0.049
 Weight loss 28 (87.5) 19 (46.3) 0.000
* Diagnosis after initial investigations.
† Wilcoxon rank-sum test.
PTB = pulmonary tuberculosis; IQR = interquartile range; BMI = body mass index.
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Nous rapportons le résultat d’investigations réalisées chez 73 adultes 
Ougandais positifs au virus de l’immunodéficience humaine (VIH) et 
présumés d’avoir une tuberculose pulmonaire (TBP). Après les 
investigations initiales, 32 de 73 patients ont eu un diagnostic de TBP. 
Sur les 41 patients restants initialement classés comme « pas de 
TBP », six ont eu un diagnostic de TBP retardé après un délai médian 
de 6 semaines. Sur les six patients perdus de vue, quatre (66%) sont 
décédés. Une recherche active et un suivi rapproché des patients VIH 
positifs présumés d’avoir une TBP indépendamment des résultats des 
investigations initiales pourrait réduire la morbidité et la mortalité 
dans ce groupe de patients vulnérables.  
En el presente artículo se comunican los resultados de las 
investigaciones realizadas en 73 adultos ugandeses aquejados de 
infección por el virus de la inmunodeficiencia humana (VIH), en 
quienes existía la presunción clínica de tuberculosis pulmonar (TBP). 
Tras los exámenes iniciales se emitió el diagnóstico de TBP en 32 de 
los 73 pacientes. De los 41 pacientes restantes, clasificados 
inicialmente ‘sin TBP’, este diagnóstico se estableció de manera tardía 
en seis de ellos y la mediana del plazo hasta el diagnóstico fue 6 
semanas. Se notificó la defunción de cuatro de los seis pacientes 
perdidos de vista durante el seguimiento (66%). La localización activa 
y el seguimiento estrecho de los pacientes con infección por el VIH y 
presunción clínica de TBP, sea cual fuere el resultado de las 
investigaciones iniciales, disminuirían la morbilidad y mortalidad en 
este grupo de pacientes vulnerables.
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